Research Keyword: intensive care unit

Knowledge framework and emerging trends of invasive pulmonary fungal infection: A bibliometric analysis (2003–2023)

This study examined 20 years of scientific research on invasive lung fungal infections using bibliometric analysis. The research found that the United States leads in fungal infection research, with emerging focus areas including COVID-19-associated fungal infections and new diagnostic methods like metagenomic sequencing. The findings show that diagnosis remains challenging and requires improved detection methods, while treatment typically involves antifungal medications like voriconazole and amphotericin-B.

Read More »

Invasive fungal infections caused by rare yeast-like fungi in adult patients: results of a prospective study

This study examined rare fungal infections in 30 critically ill adult patients over 18 years, finding that infections caused by uncommon yeasts like Trichosporon and Rhodotorula affected mainly long-term ICU patients with central lines. Despite treatment with antifungal medications, about 37% of patients died, highlighting the serious nature of these infections. The research emphasizes the importance of quickly identifying the specific fungus causing infection and using appropriate medications, along with removing infected catheters, to improve patient survival.

Read More »

Trichosporon Urinary Tract Infections: A Hidden Menace Revealed

Trichosporon is a fungus that causes urinary tract infections primarily in hospitalized patients and those with weakened immune systems. This review found that Trichosporon asahii is the most common species responsible for these infections, especially in patients with prolonged hospital stays or using immunosuppressive medications. The drug voriconazole works best against this fungus, while some common antifungal medications like amphotericin B are less effective. Accurate identification using modern laboratory techniques is crucial for proper treatment.

Read More »
Scroll to Top